Hidron Alicia I, Edwards Jonathan R, Patel J, Horan Teresa C, Sievert Dawn M, Pollock Daniel A, Fridkin Scott K: NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008, 29: 996-1011. 10.1086/591861.
Article
CAS
PubMed
Google Scholar
Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN: Antimicrobial resistance and molecular epidemiology of vancomycin-resistant Enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2007, 58: 163-170. 10.1016/j.diagmicrobio.2006.12.022.
Article
CAS
PubMed
Google Scholar
Australian Group for Antimicrobial Resistance (AGAR) posters and publications website. Vancomycin resistant enterococci in Australia: results of the AGAR surveys. 1995, http://www.agargroup.org/files/VRE%20in%20Australia.pdf. Accessed 7 June, 2012, to 2010
Webb M, Riley L, Roberts R: Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization. Clin Infect Dis. 2001, 33: 445-452. 10.1086/321891.
Article
CAS
PubMed
Google Scholar
Bell JM, Paton JC, Turnidge J: Emergence of vancomycin-resistant Enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol. 1998, 36: 2187-2190.
CAS
PubMed
PubMed Central
Google Scholar
Schouten MA, Hoogkamp-Korstanje JA, Meis JF, Voss A: Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis. 2000, 19: 816-822. 10.1007/s100960000390.
Article
CAS
PubMed
Google Scholar
Stuart RL, Kotsanas D, Webb B, Vandergraaf S, Gillespie EE, Hogg GG, Korman TM: Prevalence of antimicrobial-resistant organisms in residential aged care facilities. Med J Aust. 2011, 195: 530-533. 10.5694/mja11.10724.
Article
PubMed
Google Scholar
Burrell LJ, Grabsch EA, Padiglione AA, Grayson ML: Prevalence of colonisation with vancomycin-resistant enterococci (VRE) among haemodialysis outpatients in Victoria: implications for screening. Med J Aust. 2005, 182: 492-
PubMed
Google Scholar
Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook P, Wormser GP: Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 1994, 38: 1363-1367. 10.1128/AAC.38.6.1363.
Article
CAS
PubMed
PubMed Central
Google Scholar
Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP: Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995, 20: 1126-1133. 10.1093/clinids/20.5.1126.
Article
CAS
PubMed
Google Scholar
Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, Bland LA, Jarvis WR: Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995, 172: 993-1000. 10.1093/infdis/172.4.993.
Article
CAS
PubMed
Google Scholar
Peset V, Tallon P, Sola C, Sanchez E, Sarrion A, Perez-Belles C, Vindel A, Canton E, Gobernado M: Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis. 2000, 19: 742-749. 10.1007/s100960000360.
Article
CAS
PubMed
Google Scholar
Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, Ballow CH: A nationwide, multicenter, case–control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis. 2000, 36: 145-158. 10.1016/S0732-8893(99)00136-4.
Article
CAS
PubMed
Google Scholar
Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR: Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med. 2001, 135 (7): 484-492. 10.7326/0003-4819-135-7-200110020-00007.
Article
CAS
PubMed
Google Scholar
Roghmann M-C, McCarter RJ, Brewrink J, Cross AS, Morris JG: Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant Enterococci (VRE) in VRE-colonized patients with acute leukemia. Clin Infect Dis. 1997, 25: 1056-1059. 10.1086/516112.
Article
CAS
PubMed
Google Scholar
Stosor V, Peterson LR, Postelnick M, Noskin GA: Enterococcus faecium bacteremia: does vancomycin resistance make a difference?. Arch Intern Med. 1998, 158: 522-527. 10.1001/archinte.158.5.522.
Article
CAS
PubMed
Google Scholar
Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD: Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998, 26: 1127-1133. 10.1086/520311.
Article
CAS
PubMed
Google Scholar
Kuehnert MJ, Jernigan JA, Pullen AL, Rimland D, Jarvis WR: Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol. 1999, 20: 660-663. 10.1086/501561.
Article
CAS
PubMed
Google Scholar
Lautenbach E, Bilker WB, Brennan PJ: Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol. 1999, 20: 318-323. 10.1086/501624.
Article
CAS
PubMed
Google Scholar
Zaas A, Song X, Tucker P, Perl T: Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant Enterococci. Clin Infect Dis. 2002, 35: 1139-1146. 10.1086/342904.
Article
PubMed
Google Scholar
de Perio MA, Yarnold Paul R, Warren J, Noskin Gary A: Risk factors and outcomes associated with non–Enterococcus faecalis, non–Enterococcus faecium enterococcal bacteremia. Infect Contr Hosp Epidemiol. 2006, 27: 28-33. 10.1086/500000.
Article
Google Scholar
Olivier C, Blake R, Steed L, Salgado C: Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol. 2008, 29: 404-409. 10.1086/587647.
Article
PubMed
Google Scholar
Morris JG, Shay DK, Hebden JN, McCarter RJ, Perdue BE, Jarvis W, Johnson JA, Dowling TC, Polish LB, Schwalbe RS: Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med. 1995, 123: 250-259. 10.7326/0003-4819-123-4-199508150-00002.
Article
CAS
PubMed
Google Scholar
Papanicolaou G, Meyers B, Meyers J, Mendelson M, Lou W, Emre S, Sheiner P, Miller C: Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis. 1996, 23: 760-766. 10.1093/clinids/23.4.760.
Article
CAS
PubMed
Google Scholar
Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW: Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis. 1996, 23: 767-772. 10.1093/clinids/23.4.767.
Article
CAS
PubMed
Google Scholar
Carmeli Y, Eliopoulos GM, Samore MH: Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis. 2002, 8: 802-807. 10.3201/eid0808.010418.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chavers LS, Moser SA, Funkhouser E, Benjamin WH, Chavers P, Stamm AM, Waites KB: Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant Enterococci. Microb Drug Resist. 2003, 9: S69-S77. 10.1089/107662903322541928.
Article
CAS
PubMed
Google Scholar
Nguyen GC, Leung W, Weizman AV: Increased risk of vancomycin-resistant Enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States. Inflamm Bowel Dis. 2011, 17: 1338-1342. 10.1002/ibd.21519.
Article
PubMed
Google Scholar
McKinnell JA, Kunz DF, Chamot E, Patel M, Shirley RM, Moser SA, Baddley JW, Pappas PG, Miller LG: Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage. Infect Control Hosp Epidemiol. 2012, 33: 718-724. 10.1086/666331.
Article
PubMed
Google Scholar
Worth LJ, Thursky KA, Seymour JF, Slavin MA: Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol. 2007, 79: 226-233. 10.1111/j.1600-0609.2007.00911.x.
Article
PubMed
Google Scholar
Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D: Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia. Clin Microbiol Infect. 2011, 18: 388-394.
Article
PubMed
Google Scholar
Patel R: Clinical impact of vancomycin-resistant Enterococci. J Antimicrob Chemother. 2003, 51 (iii): 13-21.
Google Scholar
Kaye KS, Harris AD, Samore M, Carmeli Y: The case-case–control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Contr Hosp Epidemiol. 2005, 26: 346-351. 10.1086/502550.
Article
Google Scholar
Barrall DT, Kenney PR, Slotman GJ, Burchard KW: Enterococcal bacteremia in surgical patients. Arch Surg. 1985, 120: 57-63. 10.1001/archsurg.1985.01390250049008.
Article
CAS
PubMed
Google Scholar
Pallares R, Pujol M, Pena C, Ariza J, Martin R, Gudiol F: Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia: a matched case–control study. Arch Intern Med. 1993, 153: 1581-1586. 10.1001/archinte.1993.00410130103010.
Article
CAS
PubMed
Google Scholar
Mikulska M, Del Bono V, Prinapori R, Boni L, Raiola A, Gualandi F, Van Lint M, Dominietto A, Lamparelli T, Cappellano P, Bacigalupo A, Viscoli C: Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2010, 12: 505-512. 10.1111/j.1399-3062.2010.00544.x.
Article
CAS
PubMed
Google Scholar
Gray J, Marsh PJ, Stewart D, Pedler SJ: Enterococcal bacteraemia: a prospective study of 125 episodes. J Hosp Infect. 1994, 27: 179-186. 10.1016/0195-6701(94)90125-2.
Article
CAS
PubMed
Google Scholar
Caballero-Granado FJ, Becerril B, Cisneros JM, Cuberos L, Moreno I, Pachon J: Case–control study of risk factors for the development of enterococcal bacteremia. Eur J Clin Microbiol Infect Dis. 2001, 20: 83-90.
CAS
PubMed
Google Scholar
Sitges-Serra A, Lopez M, Girvent M, Almirall S, Sancho J: Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg. 2002, 89: 361-367. 10.1046/j.0007-1323.2001.02023.x.
Article
CAS
PubMed
Google Scholar
Patel R, Badley AD, Larson-Keller J, Harmsen WS, Ilstrup DM, Wiesner RH, Steers JL, Krom RA, Portela D, Cockerill FR, Paya CV: Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation. 1996, 61: 1192-1197. 10.1097/00007890-199604270-00013.
Article
CAS
PubMed
Google Scholar
Dutka-Malen S, Evers S, Courvalin P: Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 1995, 33: 24-27.
CAS
PubMed
PubMed Central
Google Scholar
McGregor JC, Perencevich EN, Furuno JP, Langenberg P, Flannery K, Zhu J, Fink JC, Bradham DD, Harris AD: Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol. 2006, 59: 1266-1273. 10.1016/j.jclinepi.2006.01.016.
Article
PubMed
Google Scholar
Pregibon D: Goodness of link tests for generalized linear models. J Roy Stat Soc C Appl Stat. 1980, 29: 15-24.
Google Scholar
Suppola JP, Kuikka A, Vaara M, Valtonen VV: Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteraemia. Scand J Infect Dis. 1998, 30: 153-157. 10.1080/003655498750003546.
Article
CAS
PubMed
Google Scholar
Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB: Effect of antibiotic therapy on the density of vancomycin-resistant Enterococci in the stool of colonized patients. New Engl J Med. 2000, 343: 1925-1932. 10.1056/NEJM200012283432604.
Article
CAS
PubMed
PubMed Central
Google Scholar
Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, Lee YJ, Dubin KA, Socci ND, Viale A, Perales MA, Jenq RR, van den Brink MR, Pamer EG: Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012, 55: 905-914. 10.1093/cid/cis580.
Article
CAS
PubMed
PubMed Central
Google Scholar
Harris A, Samore M, Lipsitch M, Kaye K, Perencevich E, Carmeli Y: Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis. 2002, 34: 1558-1563. 10.1086/340533.
Article
PubMed
Google Scholar
Timmers GJ, van der Zwet WC, Simoons-Smit IM, Savelkoul PH, Meester HH, Vandenbroucke-Grauls CM, Huijgens PC: Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol. 2002, 116: 826-833. 10.1046/j.0007-1048.2002.03339.x.
Article
PubMed
Google Scholar
Sedgwick P: Case–control studies: sources of bias. BMJ. 2011, 343: d6284-10.1136/bmj.d6284.
Article
Google Scholar